Understanding patient and provider preferences in management of metastatic renal cell carcinoma (mRCC)

被引：0
|
作者：
Yazdanpanah, Omid
Benjamin, David Joseph
Vosoughi, Elham
Raad, Ali
Popal, Medina
Kongtim, Piyanuch
Mar, Nataliya
Rezazadeh, Arash
机构：
[1] Univ Calif Irvine, Div Hematol Oncol, Orange, CA 92668 USA
[2] Hoag Family Canc Inst, Newport Beach, CA USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Chao Comprehens Canc Ctr, Stern Ctr Canc Clin Trials & Res, Orange, CA USA
[5] Univ Calif Irvine, Orange, CA 92668 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16530
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
    Gupta, Kiran
    Miller, Jeffrey D.
    Li, Jim Z.
    Russel, Mason W.
    Charbonneau, Claudie
    CANCER TREATMENT REVIEWS, 2008, 34 (03) : 193 - 205
  • [32] Metastatic Renal Cell Carcinoma (mRCC) Clinical Evidence and Quality of Supply in Germany
    Krause, Andreas
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (12) : 795 - 795
  • [33] Sunitinib in patients with cytokine-refiractory metastatic renal cell carcinoma (mRCC)
    George, D. J.
    Michaelson, M. D.
    Rosenberg, J. E.
    Redman, B. G.
    Hudes, G. R.
    Bukowski, R. M.
    Kim, S. T.
    Chen, I.
    Wilding, G.
    Motzer, R. J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 304 - 304
  • [34] SAFETY PROFILE OF SUNITINIB AND SORAFENIB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)
    Massari, Francesco
    Sperandi, Francesca
    Cricca, Antonia
    Melotti, Barbara
    Martoni, Andrea Angelo
    ANNALS OF ONCOLOGY, 2009, 20
  • [35] CARDIOTOXICITY IN METASTATIC RENAL CELL CARCINOMA (mRCC) PATIENTS TREATED WITH SUNITINIB (SU)
    Ballatore, Valentina
    Prati, Veronica
    Ruatta, Fiorella
    Galizia, Danilo
    Grignani, Giovanni
    Aglietta, Massimo
    Ortega, Cinzia
    ANTICANCER RESEARCH, 2012, 32 (05) : 1876 - 1877
  • [36] Epidemiologic, humanistic and economic burden of patients with metastatic renal cell carcinoma (MRCC)
    Banks, J.
    Gupta, K.
    Balu, S.
    Chen, E.
    Komatsuzaki, Y.
    Charbonneau, C.
    Pashos, C. L.
    VALUE IN HEALTH, 2006, 9 (06) : A276 - A276
  • [37] Body composition parameter as risk predictor in metastatic renal cell carcinoma (mRCC)?
    Heetfeld, Constantin
    Hensen, Bennet
    Eggers, Hendik
    Peters, Inga
    Kuczyk, Markus A.
    Gruenwald, Viktor
    Ivanyi, Philipp
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16506 - E16506
  • [38] Impact of early identification of brain metastases in metastatic renal cell carcinoma (mRCC)
    Parmar, Ambika
    Ghosh, Sunita
    Lalani, Aly-Khan A.
    Hansen, Aaron Richard
    Reaume, M. Neil
    Wood, Lori
    Basappa, Naveen S.
    Heng, Daniel Yick Chin
    Graham, Jeffrey
    Kollmannsberger, Christian K.
    Soulieres, Denis
    Breau, Rodney H.
    Tanguay, Simon
    Kapoor, Anil
    Pouliot, Frederic
    Bjarnason, Georg A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [39] Disparities in the receipt of palliative care (PC) in metastatic renal cell carcinoma (mRCC).
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Tandra, Pavan Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Gut microbiome composition and response to sunitinib in metastatic renal cell carcinoma (mRCC).
    Gong, Jun
    Dizman, Nazli
    Poroyko, Valeriy
    Won, Haejung
    Bergerot, Cristiane Decat
    Bergerot, Paulo Gustavo
    Maia, Manuel C.
    Hsu, Joann
    Frankel, Paul Henry
    Jones, Jeremy
    Salgia, Ravi
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
12345